Aktis Oncology, Inc. Capital Expenditures
Aktis Oncology, Inc. (AKTS) reported Capital Expenditures of $3.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- Aktis Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.26M, a 17.79% decline year-over-year.
- Aktis Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.85M, a 2.06% decline year-over-year.
- Aktis Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $1.53M.
- Aktis Oncology, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $1.89M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month |
|---|---|---|
| 2026-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.12M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.85M 10-Q · filed 2026-05-11 | |
| 2025-06-30 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.43M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $1.89M 10-Q · filed 2026-05-11 |